EXHIBIT 10.35
[***]
Represents material information which has been redacted and filed
separately with the Commission pursuant to a request for
confidential treatment pursuant to Rule 24b-2 of the Securities
Exchange Act of 1934, as amended.
AMENDED AND RESTATED
DISTRIBUTION, LICENSE AND
MANUFACTURING
AGREEMENT
by and among
REMEDENT, INC.,
REMEDENT, N.V.,
and
DEN-MAT HOLDINGS,
LLC
Dated as of June 3,
2009
|
|
|
|
Page
|
|
|
|
|
|
|
1.
|
DEFINED
TERMS.
|
1
|
|
2.
|
DISTRIBUTION
RIGHTS.
|
2
|
|
|
2.1
|
Appointment as
Distributor of the Products.
|
2
|
|
|
2.2
|
The B2C
Market.
|
2
|
|
|
2.3
|
Future Increase
of the Territory.
|
2
|
|
|
2.4
|
Potential
Future Distribution Rights.
|
3
|
|
|
2.5
|
Cessation of
Use.
|
6
|
|
3.
|
INTELLECTUAL
PROPERTY LICENSE RIGHTS.
|
6
|
|
|
3.1
|
Grants.
|
6
|
|
|
3.2
|
Rights in
Future Intellectual Property.
|
7
|
|
|
3.3
|
Delivery of
Intellectual Property.
|
8
|
|
|
3.4
|
Cessation of
Use.
|
8
|
|
|
3.5
|
Ownership of
Intellectual Property.
|
9
|
|
4.
|
MANUFACTURING
RIGHTS.
|
10
|
|
|
4.1
|
Products.
|
10
|
|
|
4.2
|
Termination of
Right.
|
10
|
|
5.
|
MANUFACTURING
RELATIONSHIP.
|
10
|
|
|
5.1
|
Soca.
|
10
|
|
|
5.2
|
Other
Manufacturers.
|
10
|
|
6.
|
PAYMENTS.
|
10
|
|
|
6.1
|
Fixed
Payments.
|
10
|
|
|
6.2
|
Other
Payments.
|
11
|
|
|
6.3
|
Manufacturing
Payment During the Exclusivity Period.
|
11
|
|
|
6.4
|
Manufacturing
Payment After the Guaranty Period.
|
12
|
|
|
6.5
|
Payment and
Reports.
|
12
|
|
7.
|
GUARANTY
PERIOD; PURCHASE RIGHTS AND OBLIGATIONS WITH RESPECT TO PRODUCTS
MANUFACTURED BY REMEDENT.
|
12
|
|
|
7.1
|
Purchases of
Units/Teeth.
|
12
|
|
|
7.2
|
Purchases of
Trays.
|
14
|
|
|
7.3
|
Off-Set.
|
14
|
|
|
7.4
|
Price
Reductions.
|
15
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
7.5
|
Option to
Extend the Guaranty Period and the Exclusivity Period.
|
15
|
|
8.
|
ORDER
FULFILLMENT, INVENTORY AND MANUFACTURING.
|
16
|
|
|
8.1
|
Order
Process.
|
16
|
|
|
8.2
|
Changes to
Orders.
|
17
|
|
|
8.3
|
Shipping; Title
and Risk of Loss.
|
17
|
|
|
8.4
|
Invoicing and
Payment.
|
17
|
|
|
8.5
|
Inventory.
|
17
|
|
|
8.6
|
Acceptance and
Return of Products.
|
17
|
|
|
8.7
|
Production and
Quality; Record.
|
18
|
|
|
8.8
|
Inspection and
Oversight by Den-Mat.
|
18
|
|
|
8.9
|
Inspection and
Oversight by Remedent.
|
18
|
|
9.
|
ENFORCEMENT OF
RIGHTS.
|
18
|
|
|
9.1
|
Distribution
Agreements.
|
18
|
|
|
9.2
|
Intellectual
Property.
|
19
|
|
10.
|
TRAINING AND
SUPPORT; DELIVERY OF CUSTOMER INFORMATION.
|
20
|
|
|
10.1
|
Manuals and
Information.
|
20
|
|
|
10.2
|
Manufacturing.
|
20
|
|
|
10.3
|
Marketing and
Sales Assistance.
|
20
|
|
|
10.4
|
Customer
Information.
|
21
|
|
|
10.5
|
Executive
Support.
|
21
|
|
|
10.6
|
Advertising.
|
21
|
|
|
10.7
|
Regulatory
Matters.
|
21
|
|
11.
|
CHANGE OF
CONTROL.
|
22
|
|
|
11.1
|
Option to
Receive Exit Fee.
|
22
|
|
|
11.2
|
Calculation of
Exit Fee.
|
22
|
|
|
11.3
|
Effect of
Payment of Exit Fee.
|
23
|
|
12.
|
PAYMENT TERMS,
TAXES AND AUDITS.
|
23
|
|
|
12.1
|
Payment.
|
23
|
|
|
12.2
|
Taxes.
|
23
|
|
|
12.3
|
Audit
Rights.
|
24
|
|
13.
|
TERM AND
TERMINATION.
|
25
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
13.1
|
Term.
|
25
|
|
|
13.2
|
Termination for
Cause.
|
25
|
|
|
13.3
|
Termination for
Convenience.
|
26
|
|
|
13.4
|
Sell-Off
Period.
|
26
|
|
|
13.5
|
Survival.
|
26
|
|
14.
|
REPRESENTATIONS
AND WARRANTIES.
|
27
|
|
|
14.1
|
Representations
and Warranties of Remedent.
|
27
|
|
|
14.2
|
Representations
and Warranties of Den-Mat.
|
32
|
|
15.
|
CLOSING.
|
34
|
|
16.
|
CLOSING
CONDITIONS.
|
34
|
|
|
16.1
|
Conditions to
the Obligation of Remedent.
|
34
|
|
|
16.2
|
Conditions to
the Obligation of Den-Mat.
|
34
|
|
17.
|
CONFIDENTIALITY.
|
35
|
|
|
17.1
|
Confidential
Information of Den-Mat.
|
35
|
|
|
17.2
|
Confidential
Information of Remedent.
|
36
|
|
18.
|
INDEMNIFICATION.
|
37
|
|
|
18.1
|
Indemnification
by Den-Mat.
|
37
|
|
|
18.2
|
Indemnification
by Remedent.
|
37
|
|
|
18.3
|
IP
Indemnity.
|
37
|
|
|
18.4
|
Indemnification
Procedures.
|
38
|
|
19.
|
FORCE MAJEURE
EVENTS.
|
38
|
|
|
19.1
|
No
Liability.
|
38
|
|
|
19.2
|
Notification.
|
39
|
|
|
19.3
|
Termination.
|
39
|
|
20.
|
MISCELLANEOUS.
|
40
|
|
|
20.1
|
Expenses.
|
40
|
|
|
20.2
|
Further
Actions.
|
40
|
|
|
20.3
|
Notices.
|
40
|
|
|
20.4
|
Binding Effect;
Assignment.
|
41
|
|
|
20.5
|
Amendment;
Waiver.
|
41
|
|
|
20.6
|
Entire
Agreement.
|
41
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
20.7
|
Severability.
|
42
|
|
|
20.8
|
Headings.
|
42
|
|
|
20.9
|
Counterparts.
|
42
|
|
|
20.10
|
Governing
Law.
|
42
|
|
|
20.11
|
Consent to
Jurisdiction.
|
42
|
|
|
20.12
|
Waiver of
Punitive and Other Damages and Jury Trial.
|
43
|
|
|
20.13
|
No Waiver;
Remedies.
|
43
|
|
|
20.14
|
No Limitation
on Competitive Activities.
|
44
|
|
|
20.15
|
No Partnership
or Joint Venture.
|
44
|
|
|
20.16
|
Jointly
Drafted; Review by Counsel.
|
44
|
|
|
20.17
|
Specific
Performance.
|
44
|
|
|
20.18
|
Interpretation.
|
44
|
|
|
20.19
|
Mitigation.
|
44
|
AMENDED AND RESTATED
DISTRIBUTION,
LICENSE AND MANUFACTURING
AGREEMENT
THIS AMENDED AND RESTATED DISTRIBUTION, LICENSE
AND MANUFACTURING AGREEMENT (this “ Agreement ”) dated as
of June 3, 2009, to be effective as of August 24, 2008 (the “
Effective Date ”) by and among Remedent, Inc., a
Nevada corporation (“ Remedent Nevada ”),
Remedent N.V., a Belgian corporation (“ Remedent
Belgium ”, and together with Remedent Nevada, “
Remedent ”), and Den-Mat Holdings, LLC, a Delaware
limited liability company (“ Den-Mat ”), and
amends and restates that certain Distribution, License and
Manufacturing Agreement dated as August 24, 2008 by and among
Remedent and Den-Mat (the “ Original Agreement
”).
WHEREAS , the parties wish to amend and restate the
Original Agreement as hereinafter set forth;
WHEREAS , Remedent has developed and desires to market,
distribute, license and sell certain products and services and
Remedent desires to appoint Den-Mat to act as the sole and
exclusive distributor of such products and services for Remedent in
the Territory (as defined below) and, with certain limitations, as
a non-exclusive distributor of such products and services for
Remedent outside the Territory;
WHEREAS , Den-Mat and Remedent have agreed that Den-Mat
will purchase certain products manufactured by or for Remedent for
a specified period of time (subject to extension) and that Den-Mat
will make royalty payments to Remedent in connection with the sale
of certain products by Den-Mat;
WHEREAS , Remedent owns certain patents, trademarks and
other intellectual property, and has rights pursuant to certain
licenses and other agreements with respect to other patents,
trademarks and other intellectual property, and Remedent desires to
grant to Den-Mat (to the extent such third party licenses and other
agreements permit) an exclusive license of such patents, trademarks
and other intellectual property in the Territory and a
non-exclusive license of such patents, trademarks and other
intellectual property in the Excluded Markets and the China Market
(each as defined below); and
WHEREAS , Remedent desires to grant Den-Mat the
non-exclusive right to manufacture or have manufactured certain
products developed by Remedent.
NOW, THEREFORE , in consideration of the foregoing and for
other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, Remedent and Den-Mat hereby agree
as follows.
Capitalized terms used herein without definition
shall have the respective meanings given to them in Schedule
1 .
|
|
Appointment
as Distributor of the Products .
|
2.1.1
Exclusive Distributor . Subject to the terms and conditions
in this Agreement, Remedent hereby appoints Den-Mat as the sole and
exclusive (even as to Remedent) distributor to market, distribute,
license and sell Products in the Territory, and Den-Mat hereby
accepts this appointment. For each market in the
Territory, Den-Mat may appoint one or more sub-distributors and
subcontractors to market, distribute, license and sell the Products
in the Territory, without Remedent’s
consent. Notwithstanding the foregoing, Den-Mat and
Remedent agree that Den-Mat’s right and license to market,
distribute and sell the Products within the Territory to the B2C
Market (as defined below) shall be non-exclusive.
2.1.2
Treatment of China . [***]
2.1.3
Non-Exclusive Distributor . [***]
2.1.4
Subdistributors . Den-Mat may authorize sub-distributors and
subcontractors to market, distribute, license and sell Products in
accordance with this Section 2 , provided that within ten
(10) days after the appointment of such sub-distributor or
subcontractor after the Effective Date, Den-Mat shall notify
Remedent of the identity, address and market of such
sub-distributor or subcontractor. Den-Mat shall not sell
or otherwise transfer Products to any sub-distributor or
subcontractor until such sub-distributor or subcontractor enters
into a form of written agreement (" Subdistributor Agreement
") with Den-Mat, which shall (a) include provisions to bind such
sub-distributor or subcontractor to terms and conditions
substantially similar to the product and territorial scope and
other limitations set forth in Sections 2 and 3 and
(b) authorize Remedent to enforce such provisions.
2.2.1
Den-Mat as Supplier in the B2C Market. Subject
to the terms and conditions of this Agreement, during the Guaranty
Period and at all times thereafter, Remedent agrees to purchase,
and to cause each B2C Market Licensee to purchase, all of its
requirements for GlamSmile Product in the B2C Market, excluding the
Excluded Markets and the China Market, from Den-Mat and Den-Mat
agrees to sell to Remedent, or its B2C Market Licensee all of its
requirements for GlamSmile Product in the B2C Market, excluding the
Excluded Markets and the China Market, at a price equal to [***]
per Unit/Tooth. [***].
2.2.2
The B2C Market in North America
. [***]
|
|
Future
Increase of the Territory .
|
2.3.1
Addition of Excluded Markets . [***]
2.3.2
Addition of China Market . [***]
2.3.3
Expansion of Territory . [***]
|
2.4
|
Potential
Future Distribution Rights .
|
2.4.1
Right to Distribute Future Remedent Veneer Products
. Remedent hereby grants Den-Mat the first right to hold
sole and exclusive distribution rights to market, distribute,
license and sell all future veneer products that are not GlamSmile
Products (each, a “ Remedent Veneer Product ”)
developed (whether directly or indirectly, individually or jointly
with others) by or for Remedent (or any of Remedent’s
Affiliates) in all existing and future markets worldwide;
provided , however , that any grant of rights
developed jointly with others will be subject to the rights, if
any, of the joint developers. Remedent shall give
Den-Mat written notice of each additional Remedent Veneer Product
as the same is developed, which notice shall identify such Remedent
Veneer Product and the anticipated market
therefor. Remedent shall not market, distribute, license
or sell any Remedent Veneer Product except through a third party
pursuant to a written agreement, and Remedent shall not grant to
any Person the right to manufacture, market, license, distribute or
sell any Remedent Veneer Product unless it has complied with this
Section 2.4.1 . Prior to appointing any Person as
a distributor for any Remedent Veneer Product: Remedent shall
deliver to Den-Mat (a) at least thirty (30) days prior to entering
into such distribution agreement, a notice identifying the Remedent
Veneer Product(s) that is the subject of such distribution
agreement, the identity of the proposed distributor and a summary
of the terms and conditions of such proposed distribution
agreement, and (b) at least fifteen (15) days prior to entering
into such distribution agreement, a copy of the complete and final
proposed distribution agreement and a notice of the date on which
such distribution agreement is to be executed (the “
Proposed Remedent Veneer Signing Date
”). At any time prior to the second Business Day
preceding the Proposed Remedent Veneer Signing Date set forth in
such notice from Remedent, Den-Mat may elect, effective upon
delivery of notice to that effect to Remedent, to enter into such
distribution agreement in lieu of such other Person on the terms
and conditions set forth in such final distribution agreement (but
with appropriate modifications to the terms thereof to the extent
any of the terms of such final distribution agreement are unique to
such other Person and are incapable of performance by
Den-Mat). If Den-Mat notifies Remedent that it elects to
enter into such distribution agreement in lieu of such other
Person, Den-Mat and Remedent shall promptly thereafter negotiate in
good faith any appropriate modifications to the terms thereof, to
the extent any of the terms of such final distribution agreement
are unique to such other Person and are incapable of performance by
Den-Mat, and execute and deliver such distribution
agreement. If Den-Mat does not deliver a notice of
exercise with respect to any distribution agreement for Remedent
Veneer Product(s) prior to the second Business Day preceding the
Proposed Remedent Veneer Signing Date, as referred to above, then
during the ten (10) Business Day period commencing with such
Proposed Remedent Veneer Signing Date, Remedent and such other
Person may enter into the final distribution agreement, provided
there is no modification of the terms thereof from the final
version provided to Den-Mat. If Remedent and such Person
do not enter into a distribution agreement within the ten (10)
Business Day period referred to in the preceding sentence, Remedent
shall not thereafter enter into a distribution agreement with
respect to the Remedent Veneer Product(s) subject to such agreement
(with such Person or any other Person) without first again
complying with each of the procedures set forth in this Section
2.4.1 .
2.4.2
Right of First Offer on Other Remedent Potential Products
. Remedent hereby grants Den-Mat the right of first
offer to have the sole and exclusive worldwide right to market,
distribute, license and sell all of the Other Potential Products
(a) worldwide, or alternatively, (b) in one or more of the United
States, the United Kingdom and Canada. Remedent shall
give Den-Mat written notice of each Other Potential Product as the
same is developed, which notice shall identify such Other Potential
Product and the anticipated market therefor. During the
forty-five (45) day period after delivery of such notice, Remedent
shall provide such information and access to its development,
marketing and sales personnel as Den-Mat may reasonably request in
order to evaluate such Other Potential Product. On or
before the expiration of such forty-five (45) day period, Den-Mat
shall notify Remedent if it elects to exercise the rights granted
under this Section 2.4.2 , and if Den-Mat fails to notify
Remedent during such forty-five (45) day period it will be deemed
to have waived its rights under this Section 2.4.2 with
respect to such Other Potential Product. If Den-Mat
delivers such a notice, Den-Mat and Remedent shall promptly
commence negotiations with respect to the terms and conditions on
which Den-Mat will become the sole and exclusive distributor for
such Other Potential Product on a worldwide basis or in one or more
of the United States, the United Kingdom and Canada, and Den-Mat
and Remedent shall engage in such negotiations in good
faith. During the period commencing on the delivery of
such notice by Remedent and ending on the later of (a) the end of
such forty-five (45) day period, or, if earlier, the date Den-Mat
notifies Remedent that it will not exercise its rights under this
Section 2.4.2 with respect to such Other Potential Product
or (b) the date negotiations between Den-Mat and Remedent with
respect to a potential distribution agreement with respect to such
Other Potential Product terminate, Remedent shall not directly
distribute, nor shall it authorize any Person to distribute, such
Other Potential Product. If Remedent notifies Den-Mat of
any Other Potential Product and Den-Mat does not deliver to
Remedent the notice of exercise referred to above or reach an
agreement with Remedent to become a distributor with respect to
such Other Potential Product, or Den-Mat waives the right of first
offer under this Section 2.4.2 , Remedent may thereafter
market , distribute, license and sell such Other Potential Product,
including the use of sub-distributors and subcontractors,
provided , however , Remedent shall not designate any
licensee, subcontractor or distributor for such Other Potential
Product on a worldwide basis or in the United States, the United
Kingdom or Canada except as hereafter provided in this Section
2.4.2 .
(i)
Appointment Within Six Months . If Remedent
notifies Den-Mat of any Other Potential Product and Den-Mat does
not become the sole and exclusive distributor of such Other
Potential Product, either because Den-Mat does not exercise its
rights under this Section 2.4.2 with respect to such Other
Potential Product or, having exercised such rights, is unable to
reach agreement with Remedent with respect to the terms and
conditions of such distribution agreement, Remedent may designate
another Person as the exclusive distributor of such Other Potential
Product worldwide or in one or more of the United States, the
United Kingdom and Canada at any time during the six (6) month
period after the later of the expiration of the forty five (45) day
period referred to above or the date Remedent and Den-Mat terminate
their negotiations regarding the terms and conditions of such
distribution agreement; provided , however , if
Den-Mat delivered a notice of exercise with respect to such Other
Potential Product during the forty five (45) day period referred to
above, the terms and conditions of the distribution agreement with
such other Person shall not be more favorable to such other Person
than the terms and conditions last offered in writing by Remedent
to Den-Mat. If Remedent has not entered into an
exclusive distribution agreement with respect to such Other
Potential Product on a worldwide basis or in the United States, the
United Kingdom or Canada, as the case may be, within the six (6)
month period referred to in the preceding sentence,
it may not thereafter appoint a distributor for such Other
Potential Product in such territory unless it again complies with
the procedures set forth above in this Section 2.4.2
.
(ii)
Different Scope . If Remedent notifies Den-Mat of
any Other Potential Product and Den-Mat does not become the sole
and exclusive distributor of such Other Potential Product worldwide
or in the United States, the United Kingdom or Canada (as
applicable for purposes of this Section 2.4.2(ii) ), either
because Den-Mat does not exercise its rights under this Section
2.4.2 with respect to such Other Potential Product or, having
exercised such rights, is unable to reach agreement with Remedent
with respect to the terms and conditions of such distribution
agreement, Remedent may from time to time designate another Person
as a distributor of such Other Potential Product in one or more
markets less than all of the United States, the United Kingdom or
Canada or on a scope less than sole and exclusive in one or more of
such markets if Remedent: (A) delivers to Den-Mat at least thirty
(30) days prior to entering into such distribution agreement, a
notice identifying the Other Potential Product that is the subject
of such distribution agreement, the identity of the proposed
distributor and a summary of the terms and conditions of such
proposed distribution agreement, and (B) delivers to Den-Mat at
least fifteen (15) days prior to entering into such distribution
agreement, a copy of the complete and final proposed distribution
agreement and a notice of the date on which such distribution
agreement is to be executed (the “ Proposed Remedent Other
Products Signing Date ”). At any time prior to
the second Business Day preceding the Proposed Remedent Other
Products Signing Date set forth in such notice from Remedent,
Den-Mat may elect, effective upon delivery of notice to that effect
to Remedent, to enter into such distribution agreement in lieu of
such other Person on the terms and conditions set forth in such
final distribution agreement (but with appropriate modifications to
the terms thereof to the extent any of the terms of such final
distribution agreement are unique to such other Person and are
incapable of performance by Den-Mat). If Den-Mat
notifies Remedent that it elects to enter into such distribution
agreement in lieu of such other Person, Den-Mat and Remedent shall
promptly thereafter negotiate in good faith any appropriate
modifications to the terms thereof, to the extent any of the terms
of such final distribution agreement are unique to such other
Person and are incapable of performance by Den-Mat, and execute and
deliver such distribution agreement. If Den-Mat does not
deliver a notice of exercise with respect to any distribution
agreement for Other Potential Product(s) prior to the second
Business Day preceding the Proposed Remedent Other Products Signing
Date, as referred to above, then during the five (5) day period
commencing with such Proposed Remedent Other Products Signing Date,
Remedent and such other Person may enter into the final
distribution agreement, provided there is no modification of the
terms thereof from the final version provided to
Den-Mat. If Remedent and such Person do not enter into a
distribution agreement within the five (5) day period referred to
in the preceding sentence, Remedent shall not thereafter enter into
a distribution agreement with respect to the Other Potential
Product(s) subject to such agreement (with such Person or any other
Person) without first again complying with each of the procedures
set forth in this Section 2.4.2(ii) (and if more than six
(6) months have passed since Remedent last delivered the notice
contemplated by the second sentence of this Section 2.4.2 ,
also comply with each of the other provisions of this Section
2.4.2 ).
2.5.1
End of Exclusivity Period . Upon expiration or
termination of the Exclusivity Period, the sole and exclusive
distribution rights provided for in Section 2.1.1 shall be
amended, without the need for any further action by any Party, to
become non-exclusive distribution rights instead of sole and
exclusive distribution rights (with the effect that the phrase
‘the sole and exclusive (even as to Remedent)’ in
Section 2.1.1 shall be deemed to mean
‘non-exclusive’ even if the text is not physically
modified).
2.5.2
End of Agreement . Upon termination of this
Agreement or, if later, upon the conclusion of any applicable
Sell-Off Period, Den-Mat shall cease having rights to market,
distribute, license and sell Products in the Territory.
|
|
Intellectual
Property License Rights .
|
3.1.1
Use of Existing Intellectual Property in the Territory
. Subject to the terms and conditions in this Agreement,
Remedent hereby grants to Den-Mat a sole and exclusive (even as to
Remedent) transferable and sublicensable right and license to use
within the Territory the Intellectual Property owned or used by
Remedent that is related to the Products as it exists on the
Effective Date. Notwithstanding the foregoing, (a)
Remedent retains the right to use and license to any Person
performing contract manufacturing for Remedent (concurrently with
Den-Mat’s right to use) such Intellectual Property solely in
connection with the manufacture of the Products and for internal
product development related to the Products, (b) this grant shall
not include any rights to the name or trademark
‘Remedent’, and (c) Den-Mat and Remedent agree that
Den-Mat’s right and license to use the Intellectual Property
within the Territory to the B2C Market shall be
non-exclusive. For purposes of clarity, other than in
the B2C Market (subject to the terms of this Agreement), during the
Exclusivity Period Remedent shall not use the name or trademark
‘GlamSmile’ in the Territory without the prior written
consent of Den-Mat. Notwithstanding anything to the
contrary in this Agreement, neither Remedent nor any B2C Market
Licensee nor any Affiliate, permitted successor or assignee of any
of the foregoing, shall, directly or indirectly, make any reference
or comparison in its marketing materials or in any advertising or
sales efforts to any Den-Mat product or trademark including, but
not limited to, LumiSmile, Lumineers, Liminate, or Lumitray,
without the prior written consent of Den-Mat. Upon
notice from Den-Mat of a violation of the foregoing, Remedent shall
have a 30-day period to cure. In the event Remedent
fails to cure such violation within thirty (30) days or in the
event of the occurrence of 5 separate violations in any 12 month
period (even if cured), Remedent shall forfeit its right to use,
and shall immediately cease and desist from any use of, the
"GlamSmile" trademark in the North American B2C Market during the
Guaranty Period. During the forty-five (45) day period
after the Effective Date, Den-Mat shall provide such cooperation to
Remedent as Remedent may reasonably request related to developing
and implementing guidelines for use of the trademarks included
among the Intellectual Property licensed to Den-Mat pursuant to
this Section 3.1.1 sufficient to enable Remedent to preserve
such trademarks; provided , however , Den-Mat shall
not be required to adopt or implement any such guideline to the
extent doing so would adversely affect Den-Mat's ability to comply
with the terms of this Agreement, materially impact Den-Mat's costs
of performance under this Agreement or otherwise would not be
commercially reasonable.
3.1.2
Use of Existing Intellectual Property in the Excluded
Markets . Subject to the terms and conditions in
this Agreement, Remedent hereby grants to Den-Mat a non-exclusive,
transferable and sublicensable right and license to use in the
China Market and the Excluded Markets the Intellectual Property
licensed or owned by Remedent that is related to the Products,
whether existing on the Effective Date or developed or acquired by
Remedent after the Effective Date, except (a) as specifically
identified on Schedule 3.1.2 , (b) subject to the
limitations set forth in Section 3.2 , (c) this grant shall
not include any rights to the name or trademark
‘Remedent’ and (d) use of the “GlamSmile”
name or trademark in the Excluded Markets shall be limited as
provided in Schedule 3.1.2 .
3.1.3
Use of Future Intellectual Property . Subject to
the terms and conditions in this Agreement, Remedent hereby grants
to Den-Mat a sole and exclusive (even as to Remedent) transferable
and sublicensable right and license to use within the Territory the
Intellectual Property owned or used by Remedent that is related to
the Products and is developed (whether directly or indirectly,
individually or jointly with others) by Remedent (or any of
Remedent’s Affiliates) or acquired by Remedent (or any of
Remedent’s Affiliates) after the Effective Date, except that
(a) such grant is subject to the limitations set forth in
Section 3.2 , (b) Remedent retains the right to use and
license to any Person providing contract manufacturing to Remedent
(concurrently with Den-Mat’s right to use) such Intellectual
Property solely in connection with the manufacture of the Products
for Den-Mat and for internal product development related to the
Products for Den-Mat , (c) Remedent retains
the right to use and license to any Person providing contract
manufacturing to Remedent (concurrently with Den-Mat’s right
to use) any of such Intellectual Property directly related to the
Product manufacturing process or the Tray delivery process solely
in connection with the manufacture of the Products, and (d) Den-Mat
and Remedent agree that Den-Mat’s right and license to use
the Intellectual Property within the Territory to the B2C Market
shall be non-exclusive.
|
|
Rights in
Future Intellectual Property .
|
3.2.1
Remedent . Remedent shall promptly notify Den-Mat
of any Intellectual Property developed (whether directly or
indirectly, individually or jointly with others) by Remedent (or
any of Remedent’s Affiliates) or acquired by Remedent (or any
of Remedent’s Affiliates) after the Effective Date related to
the Products and concurrently therewith deliver such Intellectual
Property to Den-Mat as provided in Section 3.3
. The grants provided in Section 3.1 shall not
apply to any Intellectual Property licensed by Remedent after the
Effective Date for which, despite commercially reasonable efforts,
Remedent is not able to obtain a sublicense or the right to grant a
sublicense enabling Remedent to grant the license contemplated by
Section 3.1 ; provided , however , Remedent
shall not thereafter use such Intellectual Property in competition
with the Products during the Exclusivity Period, except in the B2C
Market, the Excluded Markets and in the China Market or in
connection with the purpose of manufacturing the Products for
Den-Mat under the terms of this Agreement. Upon being
advised that any Intellectual Property Remedent desires to license
from another Person after the Effective Date would not be available
to Den-Mat as contemplated by Section 3.1 , Remedent shall
give prompt written notice of such event to Den-Mat and thereafter
will not license such Intellectual Property without first
cooperating with Den-Mat for a period of at least fifteen (15)
Business Days, in such manner as Den-Mat may reasonably request, to
obtain a license of such Intellectual Property, on commercially
reasonable terms, in the scope contemplated by Section 3.1
or in such more limited scope as Den-Mat may agree.
3.3
Delivery of Intellectual Property
. In connection with the licenses granted to
Den-Mat pursuant to Section 3.1, Remedent shall deliver
to Den-Mat, not less than one (1) copy of all computer object code
(in machine readable form) and all computer source code and other
technology related to the Intellectual Property of Remedent that is
related to the Products; provided, however, the source code related
to the software licensed from SensAble Technologies, Inc.
(“SensAble”) shall not be delivered and instead shall
be held in an escrow arrangement of which Remedent shall cause
Den-Mat to be a direct beneficiary in the event of Remedent’s
bankruptcy. From time to time as upgrades or updates of
the source code are developed, Remedent shall deliver to Den-Mat a
copy of each such upgrade and update. Den-Mat will
protect and maintain the confidentiality of such source code and
any confidential Intellectual Property provided to it hereunder to
the same extent as it protects and maintains the confidentiality of
its own source code and confidential Intellectual Property.
Remedent represents and warrants to Den-Mat that Remedent is not in
default under the terms and conditions of the OEM Agreement between
SensAble and Remedent dated June 30, 2008, (the “SensAble
Agreement”) and that Remedent continues to maintain its
exclusive license from SensAble for the veneer design software
under the SensAble Agreement.
3.4.1
End of Exclusivity Period . Upon expiration or
termination of the Exclusivity Period, the sole and exclusive
licenses provided in Section 3.1.1 shall be amended, without the
need for any further action by any Party, to become non-exclusive
licenses instead of sole and exclusive licenses (with the effect
that the term ‘sole and exclusive’ in Section 3.1.1
shall be deemed to mean ‘non-exclusive’ even if the
text is not physically modified). In addition, upon
expiration of the Exclusivity Period, the right of Den-Mat to use
any trademark of Remedent included among the Intellectual Property
of Remedent initially licensed under Section 3.1 shall immediately
terminate, except in connection with Den-Mat’s sale, in the
ordinary course of business, of its remaining inventory of Products
bearing such trademarks.
3.4.2
End of Agreement . Upon termination of this
Agreement or, if later, upon the conclusion of any applicable
Sell-Off Period, Den-Mat shall cease using all Intellectual
Property of Remedent and all materials, in any format or media,
bearing or using the Intellectual Property of Remedent, and
promptly return or destroy all tangible and electronic copies of
such Intellectual Property, as requested by Remedent, and upon the
request of Remedent, certify such destruction in writing.
Notwithstanding the foregoing provisions of this Section 3.4.2,
Den-Mat may retain one (1) copy of the Intellectual Property of
Remedent for Den-Mat’s internal compliance purposes, provided
Den-Mat shall protect and maintain the confidentiality of the
Intellectual Property retained by it to the same extent as it
protects and maintains the confidentiality of its own Intellectual
Property.
|
|
Ownership of
Intellectual Property .
|
3.5.1
Independently Developed Intellectual Property
. Subject to Section 3.5.2 , each Party shall
have the sole and exclusive right to apply for, prosecute and
obtain all rights, grants, registrations, orders or proprietary
interests of any nature, including, without limitation, patents,
copyrights, industrial design and trademark and service mark
registrations and any other registrations or grants of rights that
are analogous thereto in any and all countries throughout the world
in respect of Intellectual Property now owned or independently
developed by such Party after the Effective Date. In
addition, with respect to any Intellectual Property related to the
Products developed by Remedent (and not subject to Section
3.5.2 ), Remedent, in its sole discretion at its own cost and
expense may apply for, prosecute and obtain all rights, grants,
registrations, orders or proprietary interests of any nature,
including, without limitation, patents, copyrights, industrial
design and trademark and service mark registrations and any other
registrations or grants of rights that are analogous thereto in any
and all countries throughout the world, in each case as reasonably
requested by Den-Mat, and take such other actions as Den-Mat may
reasonably request to protect such Intellectual
Property. In the event Remedent fails to take any action
reasonably requested by Den-Mat as described in the preceding
sentence: (a) Den-Mat may take such action, (b) Remedent hereby
authorizes Den-Mat to take any such action in its name, (c)
Remedent shall provide such assistance as Den-Mat may reasonably
request in connection therewith, (d) Den-Mat shall be reimbursed
for the costs and expenses incurred by it in connection with such
actions as a priority payment from any sale, license fees,
royalties, proceeds of infringement actions or other amounts
received by Remedent or Den-Mat with respect to such Intellectual
Property in the territory covered by such rights, grants,
registration orders or proprietary interests, (e) Remedent shall be
reimbursed for the costs and expenses incurred by it in connection
with providing cooperation to Den-Mat related to obtaining such
rights, grants, registration orders or proprietary interests as a
second priority payment from any sale, license fees, royalties,
proceeds of infringement actions or other amounts received by
Remedent or Den-Mat with respect to such Intellectual Property in
the territory covered by such rights, grants, registration orders
or proprietary interests, (f) each of Den-Mat and Remedent shall
take such actions as the other may reasonably request to implement
the provisions of this Section 3.5.1 with respect to any
particular Intellectual Property and (g) the rights, grants,
registration orders or proprietary interests so obtained shall be
jointly owned by Remedent and Den-Mat.
3.5.2
Jointly Arising Intellectual Property . In the
event the Parties jointly develop any Intellectual Property related
to the Products for which a patent or copyright would be available,
and if either Remedent or Den-Mat desires to pursue a patent or
copyright on such Intellectual Property in any jurisdiction, then
the Party who desires to pursue such patent or copyright (in this
capacity, the “ Filing Party ”), shall deliver a
notice (a “ Notice of Intent to File ”) to the
other Party identifying the subject Intellectual Property, whether
the filing will be for a patent or copyright and the jurisdiction
in which such filing will be made. The Party receiving
such Notice of Intent to File may then elect to participate in such
filing, in which case it shall cooperate with the Filing Party in
connection with such filing and the subsequent prosecution thereof
and share the related costs and expenses evenly with the Filing
Party. If the Party receiving such Notice of Intent to
File does not deliver to the Filing Party a notice that it elects
to participate in such filing and prosecution within thirty (30)
days after receiving such Notice of Intent to File, the Filing
Party may proceed with such filing and prosecution
individually. If a Filing Party proceeds with such a
filing and prosecution individually: (a) the other Party hereby
authorizes the Filing Party to identify such Party as a co-owner of
the subject Intellectual Property and a co-holder of the rights
filed for, (b) the other Party shall provide such assistance as the
Filing Party may reasonably request in connection therewith, (c)
the Filing Party shall be reimbursed for the costs and expenses
incurred by it in connection with such filing and prosecution as a
priority payment from any sale, license fees, royalties, proceeds
of infringement actions or other amounts received by Remedent or
Den-Mat with respect to such Intellectual Property in the territory
covered by such patent or copyright, (d) the Filing Party shall be
reimbursed for the costs and expenses incurred by it in connection
with providing cooperation as a second priority payment from any
sale, license fees, royalties, proceeds of infringement actions or
other amounts received by Remedent or Den-Mat with respect to such
Intellectual Property in the territory covered by such patent or
copyright, (e) each of Den-Mat and Remedent shall take such actions
as the other may reasonably request to implement the provisions of
this Section 3.5.2 with respect to such Intellectual
Property and (f) the patents or copyrights so obtained shall be
jointly owned by Remedent and Den-Mat. In order to avoid
future misunderstandings, the Parties agree that any Intellectual
Property related to upgrading the Tray shall be deemed to be
jointly developed Intellectual Property for all
purposes.
Remedent hereby grants to
Den-Mat the non-exclusive worldwide right to manufacture and
produce the Products or have the Products manufactured and produced
for Den-Mat.
Upon termination of this
Agreement, Den-Mat shall cease having the right to manufacture
Products. For purposes of clarity, termination of the
Exclusivity Period separate from the termination of this Agreement
shall not affect the rights granted by Section 4.1
.
|
|
Manufacturing Relationship.
|
5.2
Other Manufacturers . [***]
6.1.1
Closing Date Payment . Subject to the terms and
conditions of this Agreement (including the satisfaction of the
closing conditions described in Section 16 ), Den-Mat shall
make an initial non-refundable payment of Two Million Four Hundred
Twenty Five Thousand Dollars ($2,425,000) (the “ Upfront
Payment ”) to Remedent within two (2) Business Days after
the Closing Date. Remedent hereby acknowledges receipt
of the Upfront Payment.
6.1.2
Contract Period Payments . Den-Mat shall make a
payment of Two Hundred Fifty Thousand Dollars ($250,000) with
respect to each of the first three Contract Periods, which, with
respect to each such Contract Period, shall be due and payable upon
the scheduled expiration of such Contract Period. If the
Guaranty Period is terminated prior to the end of any such Contract
Period pursuant to Section 13.2.2 , no payment shall be made
pursuant to this Section 6.1.2 with respect to such Contract
Period. If the Guaranty Period is terminated prior to
the end of any such Contract Period, Den-Mat shall pay to Remedent
within thirty (30) days after such termination an additional [***]
for each Tray sold in the Contract Period in which the Guaranty
Period was terminated, not to exceed Two Hundred Fifty Thousand
Dollars ($250,000).
6.1.3
Periodic Payments . As additional paid-up
royalties in consideration of the exclusive rights granted to
Den-Mat under Sections 2 and 3 , Den-Mat shall make
payments in the aggregate amount of Five Hundred Thousand Dollars
($500,000) to Remedent at the times and in the amounts provided in
Schedule 6.1.3 ; provided , however ,
Den-Mat’s obligation to make each such payment shall be
conditioned upon prior delivery to Den-Mat of evidence, reasonably
satisfactory to Den-Mat, that Remedent is in compliance with its
obligations under Section 10.3.3 at the time of such payment
or will be in such compliance simultaneously with the making of any
such payment.
6.2.1
First Sale of Tray . Den-Mat shall make a payment
of One Million Dollars ($1,000,000) to Remedent promptly after
Den-Mat manufactures a case of Units/Teeth using the Tray system in
a Tray manufactured using the GlamSmile Technology and Processes at
a facility owned or leased by Den-Mat (a “ Den-Mat
Facility ”) which is deemed by Den-Mat working together
in good faith with Remedent to be saleable to a
customer. Den-Mat shall notify Remedent of the
satisfaction of the condition to the payment under this Section
6.2.1 promptly after becoming aware of the satisfaction of such
condition. Remedent hereby acknowledges receipt of the
payment of the amount due under this Section 6.2.1
.
6.2.2
Completion of Training . Den-Mat shall make a
payment of One Million Dollars ($1,000,000) to Remedent promptly
after completion of training regarding the manufacturing equipment,
as described on Schedule 10.2 . Remedent hereby acknowledges
receipt of the payment of the amount due under this Section
6.2.2 .
6.2.3
Sale of Units/Teeth . Den-Mat shall make a
payment of One Million Dollars ($1,000,000) to Remedent upon the
first to occur of (a) February 1, 2009 or (b) the date thirty (30)
days after Den-Mat sells GlamSmile Products incorporating [***]
Units/Teeth to customers regardless of whether direct sales of
Units/Teeth are sold in Trays and regardless of whether Den-Mat has
manufactured such Units/Teeth in a Den-Mat Facility or has
purchased such Units/Teeth from Remedent; provided ,
however , that if such payment date would be on or before
January 1, 2009, Den-Mat shall make the milestone payment described
in this Section 6.2.3 on January 1, 2009. Den-Mat
shall notify Remedent of the satisfaction of the condition to the
payment under this Section 6.2.3 promptly after becoming
aware of the satisfaction of such condition. Remedent hereby
acknowledges receipt of the payment of the amount due under this
Section 6.2.3 .
|
|
Manufacturing Payment During the Exclusivity
Period .
|
6.3.1
Royalty for Products Manufactured Using Tray Technology
. Except as otherwise set forth in Section 7 ,
for each sale during the Exclusivity Period by Den-Mat of Products
manufactured by Den-Mat using the GlamSmile Tray Technology,
Den-Mat shall pay to Remedent a royalty payment equal to [***] of
Den-Mat’s Net Wholesale Price per Unit/Tooth used in the Tray
for such sales; provided , however , (a)
Den-Mat’s obligations to pay such royalties shall apply only
to sales after Den-Mat sells the first Tray manufactured in a
Den-Mat Facility and (b) if the aggregate payments of [***] are
paid by Den-Mat pursuant to Sections 6.2.1 and 6.2.2
, no royalty will be payable with respect to sales of the first
[***] Teeth/Units manufactured by Den-Mat.
6.3.2
Royalty for Products Manufactured Using Non-Tray Technology
. Except as otherwise set forth in Section 7
, for each sale during the Exclusivity Period by Den-Mat of
Products manufactured by Den-Mat using the GlamSmile Non-Tray
Technology (and not covered by Section 6.3.1 ), Den-Mat
shall pay to Remedent a royalty payment equal to [***] of
Den-Mat’s Net Wholesale Price per Unit/Tooth used in such
Product or, if such Product is a Unit/Tooth, [***] of
Den-Mat’s Net Wholesale Price per Unit/Tooth.
|
|
Manufacturing Payment After the Guaranty
Period .
|
6.4.1
Royalty for Products Manufactured Using Tray Technology
. For each sale after the Guaranty Period by Den-Mat of
Products manufactured by Den-Mat using the GlamSmile Tray
Technology, Den-Mat shall pay to Remedent a royalty payment equal
to [***] of Den-Mat’s Net Wholesale Price per Unit/Tooth used
in the Tray for such sale.
6.4.2
Royalty Payments for Products Manufactured Using Non-Tray
Technology . Except as otherwise set forth in
Section 7 , for each sale after the Guaranty Period by
Den-Mat of Products manufactured by Den-Mat using the GlamSmile
Non-Tray Technology (and not covered by Section 6.4.1 ),
Den-Mat shall pay to Remedent a royalty payment equal to [***] of
Den-Mat’s Net Wholesale Price per Unit/Tooth used in such
Product or, if such Product is a Unit/Tooth, [***] of
Den-Mat’s Net Wholesale Price per Unit/Tooth.
6.5
Payment and Reports . For purposes of Sections
6.3 and 6.4 , a sale shall be deemed to have been made
by Den-Mat at the time the related revenue is recognized by Den-Mat
for its internal accounting purposes (in accordance with
GAAP). Within sixty (60) days after the end of each
calendar quarter, Den-Mat shall deliver to Remedent a certified
statement from an officer of Den-Mat setting forth (a) the total
amount of Den-Mat sales of Products manufactured using the
GlamSmile Tray Technology during such quarter, (b) the total amount
of Den-Mat sales of Products manufactured using the GlamSmile
Non-Tray Technology during such quarter, (c) only for the calendar
quarters in which the Guaranty Period commences and terminates, the
amount of sales in such calendar quarter that were made during the
Guaranty Period and the amount of sales in such calendar quarter
that were made before or after the Guaranty Period, as applicable,
(d) a calculation of the royalty offset, if any, pursuant to
Section 6.3.1 , (e) a calculation of the royalties payable
to Remedent under Sections 6.3 and 6.4 and (f) the
amount of such royalties attributable to sales in each of the
United States, the United Kingdom and
Canada. Concurrently with delivering such statement
Den-Mat shall pay to Remedent the amount of the royalty payment set
forth on such statement.
|
|
Guaranty
Period; Purchase Rights and Obligations With Respect to Products
Manufactured by Remedent.
|
|
|
Purchases of
Units/Teeth .
|
7.1.1
Minimum Purchases . Den-Mat shall have the
obligation to purchase [***] Units/Teeth from Remedent, without a
Tray delivery system (subject to reductions in accordance with
Section 7.3 ), during each of the first three Contract
Periods; provided , however , if the final Contract
Period terminates prior to its scheduled termination date other
than as a result of a termination pursuant to Section 13.2.1
, such obligation shall be prorated in such final Contract Period
based on the number of days in such Contract Period divided by
365. Den-Mat shall have the right (but not the
obligation) to purchase Units/Teeth from Remedent prior to the
commencement of the Guaranty Period. The minimum
purchase requirement set forth above shall be satisfied in the
following manner. During each month of the first
Contract Period, Den-Mat shall purchase from Remedent the
lesser of (a) all of Remedent’s production capacity of
Units/Teeth for that month over and above the number of trays to be
purchased by Den-Mat pursuant to Section 7.2.1
(“Remedent’s Production Capacity”), and (b) [***]
Units/Teeth per month. The first “Contract
Period” shall mean the period beginning on the first day of
the Guaranty Period and continuing for the greater of (i)
fifteen (15) months and (b) the number of months as will be
required for Den-Mat to purchase [***] Units/Teeth based on the
purchase requirements set forth in the preceding
sentence. For example, if Remedent’s Production
Capacity begins and remains at [***] Units/Teeth per month, then
the first Contract Period would be 20 months. If
Remedent’s Production Capacity begins at [***] Units/Teeth
per month and then, after 8 months, increases to [***] Units/Teeth
per month, the first Contract Period would be 18 months (since
Den-Mat would buy [***] Units per month for 8 months ([***] Units)
and then [***] Units per month for 10 months ([***] Units) for a
total of [***] Units. During each month of the second,
third and each subsequent Contract Period occurring in each case
while the Guaranty Period is in effect, Den-Mat shall purchase from
Remedent the lesser of (a) all of Remedent’s
Production Capacity for that month, and (b) [***] Units/Teeth per
month. The second and each subsequent “Contract
Period” shall mean the period beginning on the next day
following the end of the preceding Contract Period and continuing
for the greater of (i) twelve (12) months and (b) the number
of months as will be required for Den-Mat to purchase [***]
Units/Teeth based on the purchase requirements set forth in the
preceding sentence.
7.1.2
Additional Right to Purchase . Den-Mat shall have
the right (but not the obligation) to purchase up to an additional
[***] Units/Teeth from Remedent, without a Tray delivery system,
during each Contract Period (for clarity, this is after the first
[***] Units/Teeth have been purchased in such Contract Period
pursuant to Section 7.1.1 ); provided ,
however , if the final Contract Period terminates prior to
its scheduled termination date other than as a result of
termination pursuant to Section 13.2.1 , such obligation
shall be prorated in such final Contract Period based on the number
of days in such Contract Period divided by 365.
7.1.3
Additional Purchases . Den-Mat may purchase
Units/Teeth from Remedent, without a Tray delivery system, in
excess of the amounts referred to in Sections 7.1.1 and
7.1.2 in any Contract Year if mutually agreed by Remedent
and Den-Mat. Notwithstanding anything contained in
Section 7.1, during the Exclusivity Period, Den-Mat shall purchase
from Remedent all of its requirements for Units/Teeth in excess of
the minimum purchase requirement set forth in Section 7.1.1,
provided that the price charged by Remedent is no higher than the
lowest price at which Den-Mat could purchase such product from a
third party manufacturer, and that the quality of the product and
the terms and conditions of the sale offered by Remedent match or
exceed those offered by the third party manufacturer.
7.1.4
Pricing . Any purchase by Den-Mat of Units/Teeth
from Remedent pursuant to Sections 7.1.1 and 7.1.2
shall be at a price of [***] per Unit/Tooth. Any
purchase by Den-Mat of Units/Teeth from Remedent pursuant to
Section 7.1.3 shall be at a price mutually agreed upon by
Remedent and Den-Mat prior to the time of such sale. The
prices referred to in this Section 7.1.4 shall be subject to
adjustment pursuant to Section 7.4 and there shall be no
royalty obligation on the sale thereof by Den-Mat (unless agreed
upon by Remedent and Den-Mat as part of the price under Section
7.1.3 ).
7.2.1
Minimum Purchases . Den-Mat shall have the
obligation to purchase [***] Trays manufactured using the GlamSmile
Tray Technology from Remedent (subject to reduction as provided in
Section 7.3.2 ) during each of the first three Contract
Periods; provided , however , if the final Contract
Period terminates prior to its scheduled termination date other
than as a result of a termination pursuant to Section 13.2.1
, then such obligation shall be prorated based on the number of
days in such Contract Period prior to such termination divided by
the number of days that would be in such Contract Period if such
Contract Period had not terminated prior to its scheduled
termination.
7.2.2
Additional Purchases . Den-Mat shall have the
right (but not the obligation) to purchase additional Trays
manufactured using the GlamSmile Tray Technology from Remedent
prior to the commencement of the Guaranty Period and, during the
Guaranty Period, in excess of the minimum purchase requirements set
forth in Section 7.2.1 , in each case as mutually agreed by
Remedent and Den-Mat. Notwithstanding anything contained
in this Section 7.2, during the Exclusivity Period, Den-Mat shall
purchase from Remedent all of its requirements for Trays
manufactured using the GlamSmile Tray Technology in excess of the
minimum purchase requirement set forth in Section 7.2.1, provided
that the price charged by Remedent is no higher than the lowest
price at which Den-Mat could purchase such product from a third
party manufacturer, and that the quality of the product and the
terms and conditions of sale offered by Remedent match or exceed
those offered by the third party manufacturer.
7.2.3
Pricing . Any purchase by Den-Mat of Trays from
Remedent pursuant to this Section 7.2 shall be at the
following price per Tray (subject to adjustment in accordance with
Section 7.4 ): (a) for each of the first [***] Trays in each
of the first three Contract Periods, [***] fee plus [***] per
Unit/Tooth in the Tray (which includes the digital design fee, the
digital preview file, the delivery/placement tray, any necessary
reshaping or occlusal trays and remakes); and (b) for each Tray
after the first [***] Trays in each of the first three Contract
Periods, such price as the Parties may agree. The prices
referred to in this Section 7.2.3 shall be subject to
adjustment pursuant to Section 7.4 and there shall be no
royalty obligation on the sale by Den-Mat of the Trays referred to
in the preceding clause (a) , or, unless mutually agreed
upon by Den-Mat and Remedent, the preceding clause (b)
.
7.3.1
Teeth in Excess Trays . If Den-Mat purchases in
excess of [***] Trays during any Contract Period, the minimum
purchase requirement of [***] Units/Teeth in such Contract Period
(as described in Section 7.1.1 ) shall be offset by the
total amount of Units/Teeth that are purchased in the excess
Trays.
7.3.2
Manufacturing Delay or Defect . Any Units/Teeth
or Trays that are not delivered within the periods required by
Section 8.1 or which are Non-Conforming Products shall be
counted against the minimum purchase requirements set forth in
Section 7.1.1 and Section 7.2.1 , but shall not count
against the number of Units/Teeth Den-Mat may purchase pursuant to
Section 7.1.2 (in each case regardless of whether they are
accepted by Den-Mat).
7.4.2
Digital Design . Den-Mat shall have the right to
perform the digital design function at a Den-Mat Facility and, if
Den-Mat provides such function with respect to any order, there
shall be credited against the cost of the related Product in such
order an amount equal to [***].
7.4.3
Manufacturing Delay or Defect . With respect to
any Products that are not delivered within the periods required by
Section 8.1 or which are Non-Conforming Products, but which
are nonetheless accepted by Den-Mat, the purchase price payable for
such Product shall be discounted by an amount equal to [***] of the
full price for such Product from Remedent (for purposes of clarity,
before giving effect to any discount contemplated by Section
7.4.1 , Section 7.4.2 or otherwise).
7.5
Option to Extend the Guaranty Period and the Exclusivity
Period.
7.5.1
Extension of Guaranty Period . Provided that
Den-Mat satisfies its obligations under Sections 7.1.1 and
7.2.1 for the first three (3) Contract Periods, the Guaranty
Period shall continue after the third (3 rd )
Contract Period with such annual price adjustments as may be agreed
upon by Remedent and Den-Mat effective after the third (3
rd ) Contract Period, unless the Guaranty Period is
terminated by Den-Mat in its sole discretion upon at least nine (9)
months prior written notice of termination to
Remedent. Den-Mat may give such notice at any time, but
if such notice is given more than nine (9) months prior to the end
of the third (3 rd )
Contract Period or any subsequent Contract Period specified in such
notice, such termination shall not be effective until the end of
the third (3 rd )
Contract Period or such subsequent Contract Period, as
applicable. No later than ninety (90) days prior to the
end of each Contract Period (commencing in the third Contract
Period and continuing thereafter unless the Guaranty Period is
scheduled to expire on or before the commencement of the next
Contract Period), Remedent shall provide to Den-Mat its proposed
pricing for the subsequent Contract Period, but in no event shall
the percentage increase in the prices charged for the Products
greater than the percentage increase in the Consumer Price Index
for All Urban Consumers, as published by the U.S. Department of
Labor, for the period from the Effective Date until the date of
such proposed increase. If such proposed price
adjustment is not acceptable to Den-Mat, Remedent and Den-Mat will
negotiate in good faith to try to reach agreement on an appropriate
price adjustment for the following Contract Period. If
Den-Mat and Remedent are unable to agree upon a price adjustment
prior to the commencement of the subsequent Contract Period, then
Den-Mat shall be deemed to have accepted the best price proposal
(to Den-Mat) submitted in writing by Remedent, and such pricing
proposal shall be the pricing of the Products for such subsequent
Contract Period, provided, however, that Den-Mat may, in its
discretion, elect to terminate the Guaranty Period upon ten (10)
days notice to Remedent.
7.5.2
Non-Extension of the Guaranty Period . If the
Guaranty Period expires pursuant to Section 7.5.1 , the
licenses granted pursuant to Sections 2.1.1 and 3.1.1
shall be amended as provided in Sections 2.4.1 and
3.4.1 ; provided , however , that Den-Mat
shall not have the right to use any of Remedent’s trademarks,
including the “GlamSmile” name or brand
after the expiration of the Guaranty Period; provided ,
however , Den-Mat shall be permitted to use such trademarks
in connection with the sale of existing Products or Products
ordered from Remedent and not delivered at the time such right
terminates, in each case in the ordinary course of distributing and
selling such Products. From and after the end of the
Guaranty Period, prices for the Products Den-Mat may purchase from
Remedent shall be as Remedent and Den-Mat mutually agree;
provided , however , such prices shall be no less
favorable to Den-Mat than the best price made available by Remedent
to any other Person after giving effect to Remedent’s
published schedule of volume discounts, if any.
8.
Order Fulfillment, Inventory and
Manufacturing.
8.1
Order Process . For each purchase of Products by
Den-Mat from Remedent, Den-Mat shall deliver to Remedent a purchase
order in a form to be agreed upon by Remedent and Den-Mat,
specifying quantities and a shipping address for the Products to be
purchased. For each Product, Remedent shall have the
time period specified in Schedule 8.1 to fulfill the order,
which shall be deemed fulfilled as of receipt by Den-Mat or at the
other shipping address specified in such order. Remedent
shall not have the right to reject any order by Den-Mat that is for
Products Den-Mat is obligated or entitled to purchase pursuant to
Sections 7.1.1 , 7.1.2 , 7.2.1 and
7.2.2 . Remedent shall fulfill or cause its
subcontractors and manufacturers to fulfill all orders by Den-Mat
in connection with Den-Mat’s minimum purchase requirements
and purchase rights, as described in Sections 7.1.1 ,
7.1.2 , 7.2.1 and 7.2.2 . If
Remedent is unable to fulfill the orders for Products by Den-Mat to
satisfy Den-Mat’s minimum purchase requirements and purchase
rights, as described in Sections 7.1.1 , 7.1.2 ,
7.2.1 and 7.2.2 , within the maximum time periods set
forth on Schedule 8.1 , Den-Mat may, in its sole discretion,
refuse to accept such Product or accept such Product with the price
discount referred to in Section 7.4.3 . If
Remedent is unable to fulfill the orders for Products by Den-Mat to
satisfy Den-Mat’s minimum purchase requirements and purchase
rights, as described in Sections 7.1.1 , 7.1.2 ,
7.2.1 and 7.2.2 , Den-Mat shall have the right to
find an alternative supply of such Products (or manufacture such
Products at a Den-Mat Facility), in which case Remedent shall pay
to Den-Mat any cost incurred by Den-Mat as a result of obtaining
such Products from an alternative supply or manufacturing such
Products directly in excess of the purchase price provided in this
Agreement (inclusive of any discounts and set-offs available on the
purchase price for such Products provided in this Agreement) and
the amount of Products so acquired or manufactured by Den-Mat shall
be counted towards any minimum purchase amounts under Section
7.1.1 and 7.2.1 , as applicable. Such right
shall be in addition to, and not as an alternative to, any other
rights of Den-Mat arising from a breach of this Agreement by
Remedent. Remedent shall have the right to reject orders
by Den-Mat that are for products in excess of Den-Mat’s
minimum purchase requirements or purchase rights, as described in
Sections 7.1.1 , 7.1.2 , 7.2.1 and
7.2.2 .
8.2
Changes to Orders . Den-Mat may modify or cancel any order
by delivering to Remedent a notice describing such modification or
cancellation. In such event, in lieu of the purchase
price for the Products subject to such order Den-Mat shall pay to
Remedent: (a) with respect to a cancelled order, the cost incurred
by Remedent in connection with such order prior to delivery of the
notice of cancellation (but not more than the price for such
Product under Section 7 ) and (b) with respect to a modified
order, the purchase price for the modified Product plus the
additional cost, if any, incurred by Remedent in connection with
the completion of such order as so modified.
8.3
Shipping; Title and Risk of Loss . All Products subject
to each order shall be delivered to Den-Mat or the Person
designated as the recipient in such order at the
shipping address specified in such order, F.O.B. Remedent’s
warehouse or manufacturing facility from which such Products are
shipped. Remedent will be responsible for arranging
all transportation of Products and shall insure all Products in a
commercially reasonable manner. Title to, and risk of
loss of, the Products will pass to Den-Mat upon receipt of the
Product by Den-Mat or the Person at the shipping address designated
in the related order. Remedent shall be responsible for
all freight, insurance, and shipping costs and duties, except
Den-Mat shall be responsible for customs duties.
8.4
Invoicing and Payment . Upon delivery and acceptance of
Products, Remedent may submit to Den-Mat an invoice for those
Products consistent with Sections 7 , 8 and the other
provisions of this Agreement. Den-Mat shall pay each
proper invoice within [***] days after Den-Mat’s receipt of
such invoice.
8.5
Inventory . Remedent shall be responsible for
maintaining sufficient inventory of the Products and raw materials
to fulfill Den-Mat’s orders for the minimum purchase
requirements or Den-Mat’s purchase rights, as described in
Sections 7.1.1 , 7.1.2 , 7.2.1 and
7.2.2 . If Den-Mat provides Remedent a
written forecast of orders that Den-Mat expects to place with
Remedent (for Products in excess of Den-Mat’s minimum
purchase requirements and purchase rights), Remedent shall use
commercially reasonable efforts to maintain sufficient inventory of
Products to fulfill such orders for Den-Mat. Remedent
shall bear all costs and losses associated with the inventory of
any Products, including inventory shrink, obsolescence, aged
inventory, damage, and Products not sold to Den-Mat or another
Person.
8.6
Acceptance and Return of Products . Den-Mat shall,
within a reasonable time after the receipt of each shipment of
Products and receipt of all necessary documentation associated with
each shipment (but in no event later than seven (7)
days after receipt of such shipment), inspect the
Products and, after such inspection, (a) accept the shipment as a
whole (as to quantity and obvious damage of Products only), (b)
reject the shipment as a whole or (c) reject the Non-Conforming
Products and accept the rest; provided , however ,
that any acceptance by Den-Mat in accordance with clause (a)
or clause (c) shall not preclude any warranty claims by
Den-Mat. In rejecting any shipments either in whole or
in part, Den-Mat shall notify Remedent in writing of the reason for
the rejection and, at Remedent’s expense (including costs of
shipment) return the Non-Conforming Products to Remedent for
confirmation of the defect. With respect to any
Non-Conforming Products, Den-Mat may, at its option, (i) return
such Non-Conforming Product to Remedent at Remedent’s expense
(including costs of shipment) for repair or replacement (at
Remedent’s expense) or (ii) cancel the order and manufacture
a replacement Product. If Den-Mat elects to manufacture
a replacement Product, it shall credit against any amounts
otherwise payable under this Agreement an amount equal to the price
of such Product (and without having any obligation to pay Remedent
for the Non-Conforming Product).
8.7
Production and Quality; Record . All Products
manufactured, sold and delivered to Den-Mat by Remedent under this
Agreement shall conform to the manufacturing standards and quality
requirements described on Schedule 8.7
. Remedent shall maintain all Product quality records in
accordance with applicable laws and regulatory requirements,
including those related to medical devices, as applicable, related
to the manufacture of the Products, and will make such records
available to Den-Mat upon reasonable advance request for review and
audit. As soon as practical after the date of this
Agreement, Remedent shall obtain, and shall thereafter maintain,
the certifications set forth on Schedule 8.7 , and shall
provide such evidence of such certifications as Den-Mat may from
time to time reasonably request.
8.8
Inspection and Oversight by Den-Mat . At any time and
from time to time, Den-Mat shall have the right to send one or more
of its authorized representatives to inspect, during regular
business hours, the manufacturing and warehouse facilities of
Remedent used to manufacture, package and store
Products. Upon the request of Den-Mat, employees of
Den-Mat shall be provided with access to the facility in [***]
operated by Soca Networks Pte. Ltd., and at each other facility of
Remedent as Den-Mat may from time to time request, to facilitate
quality control and inspection of Products prior to shipment, and
Remedent will provide such employees with office space, furniture
and communications / computer facilities sufficient for them to
achieve such purposes, at Den-Mat’s sole cost and
expense. As reasonably as practical after the
commencement of the Guaranty Period, Den-Mat shall commence quality
control inspections in the [***] facility.
8.9
Inspection and Oversight by Remedent . At any time and
from time to time, Remedent shall have the right to send one or
more of its authorized representatives to inspect, during regular
business hours, the manufacturing and warehouse facilities of
Den-Mat used to manufacture, package and store
Products.
9. Enforcement
of Rights.
9.1
Distribution Agreements . From and after the Effective
Date, Remedent shall use its best efforts to enforce each
distribution agreement related to any of the Products in the
Excluded Markets and in the China Market to the fullest extent
provided therein, except in each case, with the prior written
consent of Den-Mat. Without limitation to the preceding
sentence, Remedent shall not agree to or acquiesce in any
amendment, waiver or forbearance of any provision of any such
distribution agreement, grant any extension of any such
distribution agreement or fail to enforce any right of termination
arising from a breach thereof, without, in each case, the prior
written consent of Den-Mat. During the Exclusivity
Period, without the prior written consent of Den-Mat, Remedent
shall not enter into any new distribution agreements, whether with
an existing distributor or a new distributor, with respect to any
of the Products or which would preclude the sale of Products by
Den-Mat.
9.2
Intellectual Property .
9.2.1 From
and after the date of this Agreement, Remedent, at its sole
discretion, in addition to its obligations under Section
3.5.1 , shall maintain all of its Intellectual Property related
to the Products and enforce all of its rights to protect against
any infringing or unauthorized use of such Intellectual Property by
any Person, except in each case, with the prior written consent of
Den-Mat. Without limitation to the preceding sentence,
(a) Remedent shall, at its sole discretion, pay all renewal and
maintenance fees on their trademarks, patents and other
Intellectual Property related to the Products, (b) Remedent shall
not acquiesce in any infringement by any Person of such
Intellectual Property, nor shall it waive or forbear the exercise
of its rights with respect to any such infringement, without, in
each case, the prior written consent of Den-Mat and (c) Remedent
shall not agree to or acquiesce in any amendment, waiver or
forbearance of any provision of any license or other grant by it of
any interest in any such Intellectual Property or fail to enforce
any right of termination arising from a breach thereof, without, in
each case, obtaining the prior written consent of
Den-Mat. In the event Remedent fails to take any such
action reasonably requested by Den-Mat referred to in this
Section 9.2.1 , Den-Mat may take such action, and Remedent
hereby authorizes Den-Mat to take any such action in its
name. If Remedent requests the assistance of Den-Mat in
connection with the taking of any actions by Remedent under this
Section 9.2.1 , then Den-Mat shall be entitled to recoup its
fees and expenses related thereto either from any recovery obtained
by Remedent (after Remedent has recouped its own costs and expenses
related thereto) or by off-set against its payment obligations to
Remedent under this Agreement. In addition, if Den-Mat
commences an action in accordance with this Section 9.2.1
involving th
|